Market Overview
The global Nephrology and Urology Devices Market reached a size of USD 7.1 Billion in 2024 and is projected to grow to USD 11.3 Billion by 2033. The market is expected to expand at a CAGR of 5.13% during the forecast period 2025-2033. Growth is propelled by rising incidences of kidney and urological disorders, an aging population’s demand for sophisticated medical devices, and technological advancements that improve diagnostic and therapeutic approaches. Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Nephrology and Urology Devices Market Key Takeaways
- The global nephrology and urology devices market size was USD 7.1 Billion in 2024.
- The market is forecasted to grow at a CAGR of 5.13% from 2025 to 2033.
- Increasing incidences of kidney and urinary tract disorders and technological advancements are major growth drivers.
- North America currently holds the largest market share due to advanced healthcare infrastructure and medical technology investment.
- Hospitals and clinics dominate the end-use segment, reflecting demand for comprehensive care and surgical interventions.
- Emerging markets in Asia-Pacific are witnessing rapid growth driven by healthcare infrastructure improvements and awareness.
Sample Request Link: https://www.imarcgroup.com/Nephrology-Urology-Devices-Market/requestsample
Market Growth Factors
The nephrology and urology devices market grows because of kidney diseases and urinary disorders increase like chronic kidney disease (CKD), urinary incontinence, and kidney stones. The geriatric population increases alongside unhealthy lifestyles, and diabetes and hypertension prevalence rises. These constitute key risk factors for renal diseases. Market growth should increase with more nephrology devices like dialysis machines, lithotripters, and urinary catheters being adopted.
Additionally, technology advances, including minimally intrusive surgical instruments, laser lithotripsy equipment, and dialysis equipment, should aid market expansion as they increase precision, decrease recovery time, and improve patient outcomes. Technology, like artificial intelligence and machine learning, that diagnoses and treats should increase how devices perform through better effectiveness and precision.
Another major factor that drives the nephrology and urology devices market is governments and other healthcare organizations increasingly expending for healthcare across the globe in nephrology and urology devices. Programs that fund, increased awareness about renal disorders, treatment that is subsidized, and healthcare centers that support have made advanced therapy more accessible, so this trend is expected to drive the market to grow globally.
Market Segmentation
Breakup by Product
• Ureteral Catheters: These flexible devices provide access and drainage from the ureters and are widely used in urinary obstruction management, kidney stone treatment, and post-surgical drainage.
• PCN Catheters: The largest product segment, PCN catheters drain urine from kidneys when natural flow is blocked, delivering stability and effectiveness in relieving urinary obstructions.
• Urinary Stents: Important for maintaining ureteral patency and facilitating urine flow, urinary stents are used in treating kidney stones, ureteral strictures, and post-surgical needs.
• Stone Basket: Specialized for minimally invasive kidney and ureteral stone removal, these devices reduce patient discomfort and recovery time.
• Urology Guidewires: Essential to guide other urology devices with precision during procedures like stone removal and stent placement.
• Renal Dilators: Used to safely create or expand access paths in kidney procedures such as percutaneous nephrolithotomy.
Breakup by End Use
• Hospitals and Clinics: The dominant end-use segment, these facilities extensively deploy nephrology and urology devices for diagnosing and managing kidney and urinary disorders with advanced surgical equipment.
• Ambulatory Surgery Centers: These centers support outpatient surgical procedures, leveraging nephrology and urology devices for minimally invasive surgeries and offering less costly and quicker recovery options.
Regional Insights
North America leads the global nephrology and urology devices market, driven by advanced healthcare infrastructure, a high prevalence of kidney and urological disorders, and substantial investments in medical technology. The established market benefits from adoption of advanced diagnostic and minimally invasive treatment tools, supported by strong regulatory frameworks and reimbursement systems, positioning North America as a hub for innovation and growth.
Recent Developments & News
• In August 2023, Fresenius Medical Care AG & Co. KGaA obtained FDA clearance for its Versi HD with GuideMe Software, marking a significant technological advancement in nephrology. This clearance affirms the product’s compliance with stringent U.S. healthcare safety and effectiveness standards.
Key Players
• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• Boston Scientific Corp.
• Coloplast A/S
• Cook Group Inc.
• Fresenius Medical Care AG & Co. KGaA
• Medtronic plc
• Nipro Corporation
• Nxstage Medical Inc. (Fresenius Medical Care)
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request for Customization: https://www.imarcgroup.com/request?type=report&id=3654&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
